Clinton Snow
Director/Miembro de la Junta en ICETANA LIMITED .
Cargos activos de Clinton Snow
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ICETANA LIMITED | Director/Miembro de la Junta | 08/02/2022 | - |
DIMERIX LIMITED | Director/Miembro de la Junta | 01/05/2023 | - |
PolyActiva Pty Ltd.
PolyActiva Pty Ltd. BiotechnologyHealth Technology PolyActiva Pty Ltd. develops drug-polymer conjugate technology. Its platform technology is used to make plastic components for medical devices from drugs and manufacture process is novel and provides greater flexibility over the composition of the final material and better product outcomes compared with competitor technologies. The firm has built drug-polymer conjugates from a number of drug candidates with different chemical structures and linkage points, demonstrating the plasticity of the technology and developed a number of functional co-monomers and polymer segments, which modularises the production of the final conjugate. The company was founded in February 2010 and is headquartered in Melbourne, Australia. | Director/Miembro de la Junta | - | - |
Historial de carrera de Clinton Snow
Formación de Clinton Snow.
University of Melbourne | Undergraduate Degree |
Estadísticas
Internacional
Australia | 5 |
Operativa
Director/Board Member | 3 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 3 |
Technology Services | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ICETANA LIMITED | Technology Services |
DIMERIX LIMITED | Health Technology |
Empresas privadas | 1 |
---|---|
PolyActiva Pty Ltd.
PolyActiva Pty Ltd. BiotechnologyHealth Technology PolyActiva Pty Ltd. develops drug-polymer conjugate technology. Its platform technology is used to make plastic components for medical devices from drugs and manufacture process is novel and provides greater flexibility over the composition of the final material and better product outcomes compared with competitor technologies. The firm has built drug-polymer conjugates from a number of drug candidates with different chemical structures and linkage points, demonstrating the plasticity of the technology and developed a number of functional co-monomers and polymer segments, which modularises the production of the final conjugate. The company was founded in February 2010 and is headquartered in Melbourne, Australia. | Health Technology |
- Bolsa de valores
- Insiders
- Clinton Snow
- Experiencia